Showing results (21-30 of 4,034) with videos related to
Sort By:
Pageof 404
Pharmacoepidemiology and Drug Safety|March 6, 2003
Patient information leaflets--helpful guidance or a source of confusion?Lars Bjerrum, Annette FogedPharmacoepidemiology and Drug Safety|June 19, 2003
Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III)Ryne Paulose-Ram, Rosemarie Hirsch, Charles Dillon, et al.Pharmacoepidemiology and Drug Safety|June 19, 2003
Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000Lisa G Pont, Miriam C Sturkenboom, Wiek H van Gilst, et al.Pharmacoepidemiology and Drug Safety|March 14, 2021
Identifying prescribing cascades in Alzheimer's disease and related dementias: The calcium channel blocker-diuretic prescribing cascadeSonal Singh, Noelle M Cocoros, Kevin Haynes, et al.Pharmacoepidemiology and Drug Safety|March 18, 2021
Greedy caliper propensity score matching can yield variable estimates of the treatment-outcome association-A simulation studyJoris J Komen, Svetlana V Belitser, Richard Wyss, et al.Pharmacoepidemiology and Drug Safety|December 3, 2021
High-risk opioid analgesic dispensing to adolescents 12-18 years old in South Carolina: 2010-2017William T Basco, Jenna L McCauley, Jingwen Zhang, et al.Pharmacoepidemiology and Drug Safety|November 24, 2018
A descriptive epidemiological study on the treatment options for head and neck cancer: Transition before and after approval of cetuximabShuhei Yamada, Izumi Sato, Koji KawakamiPharmacoepidemiology and Drug Safety|March 8, 2019
Accuracy of a composite event definition for hypoglycemiaJea Young Min, Caroline A Presley, Jennifer Wharton, et al.Pharmacoepidemiology and Drug Safety|March 9, 2019
Personalized benefit-risk assessments combining clinical trial and real-world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapyCathy Anne Pinto, Tommi Tervonen, Kevin Marsh, et al.Pharmacoepidemiology and Drug Safety|March 9, 2019
Clinical outcomes and risk factors of thromboprophylaxis with rivaroxaban versus aspirin in patients undergoing hip arthroplasty in low-incidence population: A nationwide study in KoreaHong Ah Kim, Ju-Yeun Lee, So Hyun Park, et al.Pageof 404